(E)-N-[2-[[[3-(4-Chlorophenyl)allyl](methyl)amino]methyl]phenyl]-4-methoxybenzenesulfonamide - CAS 1283519-40-3
Catalog: |
BB006898 |
Product Name: |
(E)-N-[2-[[[3-(4-Chlorophenyl)allyl](methyl)amino]methyl]phenyl]-4-methoxybenzenesulfonamide |
CAS: |
1283519-40-3 |
Synonyms: |
N-[2-[[[(E)-3-(4-chlorophenyl)prop-2-enyl]-methylamino]methyl]phenyl]-4-methoxybenzenesulfonamide; N-[2-[[[(E)-3-(4-chlorophenyl)prop-2-enyl]-methylamino]methyl]phenyl]-4-methoxybenzenesulfonamide |
IUPAC Name: | N-[2-[[[(E)-3-(4-chlorophenyl)prop-2-enyl]-methylamino]methyl]phenyl]-4-methoxybenzenesulfonamide |
Description: | (E)-N-[2-[[[3-(4-Chlorophenyl)allyl](methyl)amino]methyl]phenyl]-4-methoxybenzenesulfonamide (CAS# 1283519-40-3 ) is a useful research chemical. |
Molecular Weight: | 456.98 |
Molecular Formula: | C24H25ClN2O3S |
Canonical SMILES: | CN(CC=CC1=CC=C(C=C1)Cl)CC2=CC=CC=C2NS(=O)(=O)C3=CC=C(C=C3)OC |
InChI: | InChI=1S/C24H25ClN2O3S/c1-27(17-5-6-19-9-11-21(25)12-10-19)18-20-7-3-4-8-24(20)26-31(28,29)23-15-13-22(30-2)14-16-23/h3-16,26H,17-18H2,1-2H3/b6-5+ |
InChI Key: | RUAOVVIUGUOYHA-AATRIKPKSA-N |
MDL: | MFCD24369012 |
LogP: | 6.44840 |
Publication Number | Title | Priority Date |
US-2021147497-A1 | Compositions and methods for treating or preventing catecholaminergic polymorphic ventricular tachycardia | 20170706 |
PMID | Publication Date | Title | Journal |
22538403 | 20120715 | CaMKII inhibition hyperpolarizes membrane and blocks nitrergic IJP by closing a Cl(-) conductance in intestinal smooth muscle | American journal of physiology. Gastrointestinal and liver physiology |
22441800 | 20120601 | IGF-2R-mediated signaling results in hypertrophy of cultured cardiomyocytes from fetal sheep | Biology of reproduction |
22004981 | 20120115 | Examining the effect of the CaMKII inhibitor administration in the locus coeruleus on the naloxone-precipitated morphine withdrawal signs in rats | Behavioural brain research |
22009705 | 20111201 | Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias | Circulation. Arrhythmia and electrophysiology |
21325441 | 20110501 | Reducing the late sodium current improves cardiac function during sodium pump inhibition by ouabain | The Journal of pharmacology and experimental therapeutics |
Complexity: | 650 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 1 |
Exact Mass: | 456.1274415 |
Formal Charge: | 0 |
Heavy Atom Count: | 31 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 456.1274415 |
Rotatable Bond Count: | 9 |
Topological Polar Surface Area: | 67 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
-
[10340-23-5]
cis-3-Nonen-1-ol
-
[44994-28-7]
N,N,N',N'-Tetramethyl-1,5-pentanediamine
-
[79551-14-7]
Ferene Disodium Salt
-
[56507-37-0]
Metribuzin-diketo
-
[875573-66-3]
Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)-
-
[5518-18-3]
N-[2-(hexadecanoylamino)ethyl]hexadecanamide
INDUSTRY LEADERS TRUST OUR PRODUCTS